Health Care Fraud Crackdown Raises Questions About Coverage and Oversight

Fraud in health programs is a real oversight problem. The harder question is whether the latest crackdown is finding wrongdoing reliably, and whether its methods risk disrupting coverage for people who qualify. Those questions have taken on greater prominence as health costs remain a major concern and parties argue over the future of public insurance programs.

Republicans have emphasized fraud investigations as evidence that they are protecting taxpayer funds. Democrats say the effort is being used to justify cuts and target states led by their party. The debate also raises questions about whether enforcement is consistent: critics point to pardons for health industry executives convicted of fraud and staffing changes that reduced marketplace oversight.

Fraud risks are documented; the scale is disputed

Fraud and improper enrollment are not new issues. Health care providers and insurance brokers have been implicated in schemes, and watchdog investigations have found weaknesses in program safeguards. A Government Accountability Office report in March warned that Medicare’s large volume of payments creates significant fraud risks. In a separate investigation, agency staff obtained subsidized Affordable Care Act coverage for fictitious applicants.

Those findings show that enrollment and payment systems can be exploited. They do not, on their own, establish the extent of fraud in any particular state or prove that every account flagged in a review is fraudulent. That distinction matters when agencies use suspected wrongdoing to suspend payments or end people’s coverage.

A KFF survey conducted in mid-September found that 44% of respondents, including 54% of Republicans, considered fraud in government programs “extremely important” for candidates to discuss. In a separate survey by KFF and the Associated Press, fraud ranked as the leading issue rural Republican respondents wanted candidates to address. The findings suggest the subject resonates with Republican voters, even as Democrats generally have had an advantage in public confidence on health care.

Larry Levitt, KFF’s executive vice president for health policy, said that focusing on fraud gives Republicans a way to discuss health care while facing criticism over reductions to Medicaid and Affordable Care Act coverage. The political usefulness of that message does not settle whether individual enforcement actions are well supported.

Marketplace removals put that distinction to the test

The Centers for Medicare & Medicaid Services recently canceled Affordable Care Act marketplace enrollments covering 760,000 people, saying the accounts were fraudulent. Federal officials said some applications had been submitted for nonexistent consumers by brokers or agents who could receive insurance commissions.

CMS Administrator Mehmet Oz said the canceled accounts included people who had not used their coverage and some who lacked Social Security numbers. He argued that the patterns pointed to fraud. Critics counter that low use is not proof of a false application: younger and healthier people may go years without needing care. Nor does the absence of a Social Security number establish wrongdoing in every case; a newborn, for example, may be added to a parent’s plan before receiving one.

These competing explanations make the quality of the review process central. Health analysts and consumer advocates warn that a broad effort to remove fictitious accounts could also affect eligible people. The practical risk is that a person with valid coverage may lose it while trying to resolve an error, potentially at a time when they need care.

The size of marketplace enrollment in some Republican-leaning states adds to the stakes. KFF estimates that 4.5 million people in Florida and 4.1 million in Texas have marketplace coverage, together accounting for nearly 40% of national enrollment. Conservative health policy advisers say the administration tried to reduce mistaken removals by contacting consumers and requiring additional criteria before ending coverage. Brian Blase, president of the Paragon Health Institute and a former Trump health policy adviser, said critics were mischaracterizing the process.

State reviews have produced sharp disputes

The administration has announced audits of state Medicaid fraud units, increased scrutiny of program enrollment and deferred billions of dollars in federal Medicaid payments while it reviews state oversight. Democrats say the actions have focused disproportionately on states led by their party and have sometimes relied on weak evidence. The administration says its interventions are needed to protect funds for people who qualify.

New York offers a prominent example of how disputed numbers can shape the debate. Federal officials began investigating the state’s Medicaid program after alleging that personal care services, such as help with bathing, dressing and meals, had been provided to more than 5 million people. That figure would have represented roughly three-quarters of the state’s Medicaid population.

CMS later acknowledged that it had misread New York’s billing codes. The agency said the number of people who actually received the services was closer to 450,000. It continued examining the program and later suspended millions of dollars in federal support for the state’s Medicaid fraud unit, saying the unit had not produced enough indictments. Andy Schneider, a Georgetown University research professor and former senior adviser at CMS, said that a funding deferral is not a finding that fraud occurred, and criticized the way the dispute had been elevated.

California and Minnesota have faced separate funding actions. The administration withheld about $2 billion in Medicaid funding from California over concerns about oversight of some home medical services. State officials said increased spending reflected factors including higher wages for home health aides and more older people receiving care. The administration also announced plans to defer more than $500 million from Minnesota, alleging inadequate safeguards. Minnesota officials defended their oversight and challenged the decision in court.

Questions about consistency add to the criticism

Democrats have pointed to other administration decisions as evidence that the anti-fraud effort is uneven. They note that the Department of Health and Human Services recertified hundreds of insurance brokers and agents who had been suspended by the Biden administration over suspected fraud or abuse. They also cite the departure of about 200 employees from a CMS office involved in regional oversight of the health insurance marketplace.

On Oct. 3, Trump called for legislation imposing mandatory prison terms for people who defraud Medicare and Medicaid, with no option for probation. Yet he has also pardoned health industry executives convicted in major fraud cases. Among them was a nursing home operator sentenced to three years in prison for a tax scheme involving nearly $40 million. During Trump’s first term, he pardoned five executives at a Florida company convicted of Medicaid fraud. The National Health Care Anti-Fraud Association criticized pardons issued in 2021 to executives who profited from large schemes.

That record has prompted critics to question whether the administration’s approach is consistently focused on accountability. They argue that some health program reductions are being presented as anti-fraud measures while executives convicted in major cases have received pardons. The administration, meanwhile, says fraud diverts resources from eligible beneficiaries and undermines confidence in programs.

Coverage costs remain part of the argument

The fraud debate is unfolding alongside changes that affect insurance affordability. Legislation backed by Republicans is projected to reduce federal Medicaid spending by hundreds of billions of dollars over a decade. Enhanced Affordable Care Act premium subsidies expired at the end of 2025, raising costs for many people who buy marketplace coverage. Enrollment has since fallen by millions, according to the source reporting.

An analysis by the Congressional Budget Office projects that the combined changes will leave 16 million more people uninsured by 2034. Democrats are using those projections to argue for protecting coverage and affordability. Republicans are emphasizing program integrity and public spending.

Anthony Wright, executive director of Families USA, said that fighting fraud should not result in people losing coverage. That is a practical test for the current crackdown: investigators need to identify false claims and improper enrollment, while giving eligible people a clear way to correct mistakes and retain coverage.

For consumers, an allegation about a program or state does not show that a particular person’s enrollment is improper. Anyone who receives a notice about coverage or eligibility can contact their insurer or program administrator to understand what information is needed and what steps apply to their case. The broader evidence will depend on whether reviews produce verifiable findings while avoiding mistaken removals and interruptions in care.